Telomerase-negative cancer cells can maintain their telomeres by a recombination-mediated alternative lengthening of telomeres (ALT) process. We reported previously that sequestration of MRE11/RAD50/NBS1 complexes represses ALT-mediated telomere length maintenance, and suppresses formation of ALT-associated promyelocytic leukemia (PML) bodies (APBs). APBs are PML bodies containing telomeric DNA and telomere-binding proteins, and are observed only in a small fraction of cells within asynchronously dividing ALT-positive cell populations. Here, we report that methionine restriction caused a reversible arrest in G 0 /G 1 phase of the cell cycle and reversible induction of APB formation in most cells within an ALT-positive population. We combined methionine restriction with RNA interference to test whether the following proteins are required for APB formation: PML body-associated proteins, PML and Sp100; telomereassociated proteins, TRF1, TRF2, TIN2 and RAP1; and DNA repair proteins, MRE11, RAD50, NBS1 and 53BP1. APB formation was not decreased by depletion of Sp100 (as reported previously) or of 53BP1, although 53BP1 partially colocalizes with APBs. Depletion of the other proteins suppressed APB formation. Because of the close linkage between ALT-mediated telomere maintenance and ability to form APBs, the eight proteins identified by this screen as being required for APB formation are also likely to be required for the ALT mechanism.
Introduction
Human telomeres contain a linear tandem array of TTAGGG repeats bound by telomere-associated proteins, which are essential for chromosome stability and genomic integrity (de Lange, 2002) . Progressive telomere shortening in normal cells during DNA replication leads eventually to a permanent halt of cell division referred to as replicative senescence. Cancer cells bypass senescence and achieve unlimited replicative potential by activating a telomere maintenance pathway. Most cancers utilize telomerase (Greider and Blackburn, 1985) for this purpose, but a significant minority utilize an alternative lengthening of telomeres (ALT) mechanism (Bryan et al., , 1997 . Although details of the molecular mechanism of ALT are largely unknown, previous studies have shown that ALT in human cells involves telomere-telomere recombination (Murnane et al., 1994; Dunham et al., 2000) . With a few exceptions (Cerone et al., 2005; Fasching et al., 2005; Marciniak et al., 2005; Brachner et al., 2006) , the hallmarks of human ALT cells include (1) a unique pattern of telomere length heterogeneity, with telomeres that range from very short to greater than 50 kb long and (2) the presence of ALT-associated promyelocytic leukemia (PML) nuclear bodies (APBs) containing (TTAGGG)n DNA and telomere-specific binding proteins (Yeager et al., 1999) .
APBs are a subset of PML bodies that are present only in ALT cells, and are not found in mortal cells or telomerase-positive cells (Yeager et al., 1999) . In addition to constitutive components of PML bodies such as PML and Sp100, they also contain other proteins involved in DNA replication, recombination and repair including RAD51, RAD52 and RPA (Yeager et al., 1999) , RAD51D (Tarsounas et al., 2004) , BLM (Yankiwski et al., 2000; Stavropoulos et al., 2002) , WRN (Johnson et al., 2001) , RAP1 and BRCA1 (Wu et al., 2003) , MRE11, RAD50 and NBS1 (Wu et al., 2000; Zhu et al., 2000) , ERCC1 and XPF (Zhu et al., 2003) , hRAD1, hRAD9, hRAD17 and hHUS1 (Nabetani et al., 2004) , Rif1 (Silverman et al., 2004) and hnRNP A2 (Moran-Jones et al., 2005) . Formation of APBs requires NBS1, which recruits MRE11, RAD50 and BRCA1 into these structures (Wu et al., 2003; Jiang et al., 2005) . APBs are found in a minority of cells within asynchronously dividing ALT cell populations, which has led to the conclusion that they form in a cell cycledependent manner (Grobelny et al., 2000; Wu et al., 2000) . It has been suggested that APBs may have an integral role in the ALT mechanism (Yeager et al., 1999; Grobelny et al., 2000; Wu et al., 2000 Wu et al., , 2003 Molenaar et al., 2003) and, consistent with this suggestion, inhibition of ALT in some somatic cell hybrids formed by fusion of ALT and telomerase-positive cell lines resulted in a substantial decrease in APBs (Perrem et al., 2001) . Furthermore, our recent study showed that inhibition of ALT is accompanied by suppression of APBs, providing evidence for a direct link between APBs and ALT activity (Jiang et al., 2005) .
The close correlation between APBs and ALT activities justifies the use of APBs as a marker of ALT activity, although the possibility that APBs are a byproduct of the ALT process and not an integral part of the mechanism has not been excluded completely. On the basis of this notion, the genes required for APB formation are candidate ALT genes. Therefore, we developed a method for testing whether proteins are required for APB formation. This was facilitated by finding a physiological way to increase the proportion of APB-positive cells within the population from o5 to >50%. We found that restriction of methionine, an essential amino acid, can induce APB formation in 50-60% of cells within an ALT þ population. Although this occurred in several ALT cell lines that were tested, we chose IIICF/c cells for development of the assay system because this is the cell line for which the most compelling data regarding linkage between ALT activity and the ability to form APBs exists (Jiang et al., 2005) . By all parameters tested, IIICF/c is a typical ALT cell line exhibiting the characteristically heterogeneous telomere length pattern (Rogan et al., 1995) , APBs (Yeager et al., 1999) , rapid fluctuation of telomere length (Jiang et al., 2005) and circular extrachromosomal telomeric repeat DNA (Fasching CL, Jiang W-Q and Reddel RR, unpublished data) .
We have developed a novel method combining RNA interference with methionine restriction to identify genes that are involved in formation of APBs and thus are candidate ALT mechanism genes. The principle of this assay is that expression of the gene of interest is modulated before methionine restriction to determine whether its encoded protein is needed in APB formation. Our initial screen showed for the first time that PML, TRF1, TRF2, TIN2, RAP1, MRE11 and RAD50 are required for APB formation -thus identifying them as candidate ALT genes -whereas 53BP1 is dispensible.
Results

Methionine restriction induces formation of APBs in ALT cells
In ALT cells, APBs are usually somewhat larger than the PML bodies without telomeric contents, and the quantity of telomeric DNA and its binding proteins that they contain is often greater than the amount present at individual telomeres. Therefore, APBs may often be seen as large TRF1 or TRF2 foci that are much brighter than the signals from individual telomeres. In this study, APBs were mostly detected by visualizing TRF1 or TRF2 within a PML body (Figure 1a) . Also, immunostaining with either anti-TRF1 or TRF2 antibodies to detect APBs produced equivalent results (Supplementary Figure S1a ).
APBs are usually found in o5% of cells within asynchronously growing ALT cell populations. Restriction of amino acids such as cystine has been reported to promote the formation of large PML bodies in some cancer cells (Kamei, 1996 (Kamei, , 1997 . In an effort to increase APB-positive cell populations, we subjected ALT cells to methionine or cystine restriction. We found that after 4 days of methionine restriction, APB formation was induced in the majority of cells in ALT cell lines, including IIICF/c and GM847 (Figure 1a and b) , whereas cystine starvation caused substantial amounts of cell death and much less APB formation than methionine starvation (data not shown). No APBs were found upon methionine restriction of normal human IMR-90 fibroblasts ( Figure 1a ) and telomerase-positive cell lines such as GM639 and JFCF-6/hTERT-3 (Figure 1b) , indicating that the induction of APBs was ALT-specific. Moreover, double or triple immunostaining of methionine-starved ALT cells revealed no apparent changes in the composition of APBs, as evidenced by the presence of telomeric DNA, TRF1, TRF2, PML, NBS1, MRE11 and RAD50 in the APBs upon methionine restriction (Supplementary Figure S1 ; data not shown).
Induction of APBs by methionine restriction is reversible in IIICF/c cells
The data from DNA flow cytometry and immunostaining for APBs showed that around 70% of IIICF/c cells were in the G 0 /G 1 phase of cell cycle after 4 days of methionine restriction (Figure 2a ). Bromodeoxyuridine (BrdU) staining was absent from all (>99.9%) cells (Figure 2b ), indicating that methionine restriction caused all cells to undergo cell-cycle arrest, and that they predominantly arrested with G 0 /G 1 DNA content. A few cells remained BrdU-positive when homocysteine was added instead of methionine (Figure 2b ). The methionine restriction-induced growth arrest was reversible: addition of methionine to the methionine-starved cultures resulted in many cells becoming BrdU-positive after 1 day (Figure 2c ), and caused a gradual shift of cells from G 0 /G 1 to S and G2 phases (Figure 2a) . The growth arrest induced by methionine restriction was accompanied by the induction of APBs in 50-60% of the population (Figure 2d ), indicating the presence of APBs in G 0 /G 1 -arrested ALT cells. This was also reversible upon feeding with methionine, with a drastic reduction of the APB-positive population being seen 3 days later (Figure 2d ). Some BrdU-positive methioninerescued cells were also APB-positive (Figure 2c ), indicating that IIICF/c cells may be able to re-enter the cell cycle while they still contain APBs.
To confirm the observation that growth arrest occurred after methionine restriction, we examined the levels of Ki-67, a marker for proliferation, which is highly expressed in all phase of cycling cells but not in resting cells (Gerdes et al., 1983 (Gerdes et al., , 1984 . We found that only B14% of the cells were positive for Ki-67 after 4 days of methionine starvation, whereas B91.5% were positive in the control population, indicating that the vast majority of methioninestarved cells entered into resting status (Supplementary Figure S2a) . Furthermore, we examined the levels of MCM7, a core subunit of the DNA-binding MCM2-7 heterohexamer complex that plays a critical role in the initiation of replication (Lei and Tye, 2001) . Several lines of evidence have suggested that quiescent cells have lost MCM2-7 proteins (Blow and Hodgson, 2002) . We found that MCM7 was undetectable in the vast majority of cells after 4 days of methionine restriction, whereas high levels of MCM7 were present in most proliferating cells under the normal culture conditions (Supplementary Figure S2b ). On the basis of these data, we conclude that most of the methionine-starved cells had withdrawn from the cell cycle.
Screening for genes required for APB formation, and candidate genes for ALT As is characteristic of human cell lines that maintain their telomeres using the ALT mechanism, the IIICF/c line has telomeres of very heterogeneous length (Rogan et al., 1995) and forms APBs (Jiang et al., 2005) . IIICF/c cells were used in our recent study, which demonstrated a close link between the formation of APBs and ALT activity (Jiang et al., 2005) . Furthermore, the reversible nature of APB induction by methionine restriction in IIICF/c cells provides a physiological way to enrich APB-positive populations. These characteristics make IIICF/c cells a suitable system for screening not only for the proteins involved in APB formation, but also for candidate ALT genes. We did this by combining RNA interference with methionine restriction, as described in the Materials and methods section. Briefly, IIICF/c cells were treated with siRNA against a specific gene, and then subjected to methionine restriction for APB induction, before being fixed for immunostaining. Quantitation was carried out by scoring APB-positivity in cells shown by immunostaining to be depleted of the protein of interest. When knockdown resulted in a significant decrease in the proportion of APB-positive cells, it was concluded that the protein is involved in formation or maintenance of APBs. Ten candidate genes were chosen for testing: the core proteins of PML bodies, PML and Sp100; the telomere-associated proteins, TRF1, TRF2, TIN2 and hRAP1; and the DNA repair proteins, MRE11, RAD50, NBS1 and 53BP1.
PML but not Sp100 is required for APB formation PML and Sp100 are core constituents of PML bodies, which also form the outer shell of APBs. To determine the effect of disrupting PML or Sp100 on APB formation, we used 21-nucleotide siRNAs to silence PML (PML-2 siRNA) and Sp100 (Sp100-1 or Sp100-2 siRNAs). After transfection with siRNAs for 48 h, the levels of PML or Sp100 in IIICF/c cells was substantially reduced when compared to the non-silencing control (Figure 3a and b). In addition, knockdown of PML downregulated Sp100, but not vice versa. The results from the APB screening revealed that APB formation was reduced by more than 90% in cells where PML expression was undetectable ( Figure 3c , Table 1 ), indicating that PML is required for the formation of APBs. However, APB formation was not inhibited when Sp100 was depleted by either of the Sp100 siRNAs (Figure 3c Table 1) , which is consistent with our previous data showing that Sp100 is dispensible for the formation of APBs (Jiang et al., 2005) .
TRF1, TRF2, TIN2 and hRAP1 are required for APB formation Telomere-binding proteins TRF1 and TRF2 as well as their respective binding partners TIN2 and RAP1 play a pivotal role for maintaining the integrity of telomeres in telomerase-positive and normal cells (de Lange, 2005) . Western analysis showed that the levels of TRF1, TRF2, TIN2 or RAP1 were effectively downregulated 2 days after transfection with siRNAs against TRF1 (TRF1 siRNA), TRF2 (TRF2 siRNA), TIN2 (TIN2-4 siRNA) or RAP1 (RAP1-2 siRNA; Figure 4a -c). More importantly, the data showed that APBs were reduced by around 10-fold in cells where TRF1, TRF2, TIN2 or RAP1 were depleted ( Figure 4d , Table 1 ), suggesting that these proteins are required for APB formation. This was also confirmed by telomere fluorescence in situ hybridization (FISH) analysis (Table 1 ; Supplementary Figure S3) .
Furthermore, knockdown of TIN2 downregulated the levels of TRF1, whereas knockdown of RAP1 reduced c APBs were detected by co-localization of the specified proteins as assessed by immunostaining, or by co-localization of PML protein with (TTAGGG)n DNA visualized by hybridization with a labeled peptide nucleic acid (PNA) probe, or, by detection of large TRF1, TRF2 or PNA foci in the instances where PML immunostaining was not possible. the levels of TRF2 (Figure 4b and c) . Immunofluorescence analysis revealed that TRF1 foci were coregulated with TRF2 foci upon knockdown of either TRF1 or TRF2 (Figure 4d ), and similarly, TRF1 foci were co-regulated with TIN2 foci (Figures 4d and 5) . Also, knockdown of TRF2 or TIN2 abolished RAP1 foci, but although RAP1 knockdown abolished large foci of TRF2 and TIN2 (APBs), small foci (telomeres) were not significantly affected (Figures 4d and 5 ).
Each member of the MRE11/RAD50/NBS1 (MRN) complex is required for APB formation NBS1 has been reported by others and us to be indispensable for the formation of APBs (Wu et al., 2003; Jiang et al., 2005) . Our recent study also indicated that sequestration of MRN complexes by Sp100 represses both ALT and APBs (Jiang et al., 2005) . However, it remains unclear whether MRE11 and RAD50, the other two components of the MRN complex, are required for the formation of APBs. We therefore examined by APB screening the individual proteins of MRN complexes as well as 53BP1, a DNA repair protein. The effectiveness of siRNAs against MRE11 (MRE11-2 siRNA), RAD50 (RAD50-1 and -2 siRNAs), NBS1 (NBS1-2 siRNA) or 53BP1 (53BP1 siRNA) was demonstrated by Western analysis of the cells treated with the individual siRNAs (Figure 6a-c) . The data from APB screening showed that APB formation was reduced by more than 90% in cells where the expression of MRE11, RAD50 or NBS1 was undetectable, indicating that the individual components of MRN complexes are important for APB formation (Figure 6d , Table 1 ). In addition, we found that 53BP1 partially co-localized with APBs (Figure 6d ), but no apparent effects on APB formation were observed in cells depleted of 53BP1 (Table 1 ), suggesting that 53BP1 is dispensable for APB formation.
Discussion
In this study, we have shown that methionine restriction is able to induce APB formation in more than 50% of ALT cells but not in normal or telomerase-positive cells. It has been suggested that growth arrest by methionine restriction may be related to the role of methionine as a methyl donor for methylation of DNA, RNA and proteins (Lu and Epner, 2000) . Interestingly, normal cells are able to grow in culture when methionine is substituted with homocysteine because mammalian cells can convert homocysteine to methionine (Stern and Hoffman, 1986) , but most cancer cells fail to grow in the absence of methionine, even when supplemented with homocysteine (Halpern et al., 1974; Mecham et al., 1983; Stern and Hoffman, 1986) , which may result from the elevated levels of transmethylation in cancer cells as compared with normal cells (Tisdale, 1980; Stern and Hoffman, 1984; Judde et al., 1989) . It was recently reported that telomeric recombination was elevated by a decrease in methylation of sub-telomeric regions in mouse embryonic stem (ES) cells deficient for DNA Figure 5 Correlation among TRF1, TRF2, TIN2 and RAP1 foci in IIICF/c cells. Knockdown of TRF2 (top row) and TIN2 (second to the bottom row) abolished the large (APB) and small (telomeric) RAP1 foci. Also, TIN2 foci were disrupted by depletion of TRF1 (second to the top row). However, although large TIN2 foci were abolished by RAP1 knockdown, the small foci were not significantly affected (bottom row). The arrows indicate cells depleted of TRF1, TRF2, TIN2 or RAP1 with the indicated siRNAs. Bars, 10 mm.
methyltransferases (Gonzalo et al., 2006) , so it seems possible that methionine restriction could reduce levels of methylation at telomeric and subtelomeric regions, creating a favorable environment for the assembly of APBs in ALT cells.
Reversible cell-cycle block by methionine restriction has been reported in some cancer cell lines (Pavillard et al., 2004) . Here, we showed that growth arrest by methionine restriction is reversible in IIICF/c cells, and that APB-positive cells are able to re-enter the cell cycle. This was supported by our observation that BrdU was incorporated into APB-positive cells upon addition of methionine to the growth-arrested culture, and also consistent with a previous report that in an asynchronous population, APB-positive cells incorporate BrdU, and APBs are present in mitotic cells (Grobelny et al., 2000) .
We used RNA interference to determine whether knockdown of the expression of specific genes affects the proportion of APB-positive cells in the population. Although the assay was not designed specifically to distinguish between effects on APB formation and maintenance, it seems most likely that it primarily examines their formation. Under the methionine restriction conditions we describe, APB-positive cells increase most rapidly in number during day 3 and reach a plateau at day 4. We routinely quantitated APBs at day 4, and hence are most likely examining modulation of their formation, although we cannot exclude effects on maintenance of APBs that have already been assembled. 
Screen for ALT genes W-Q Jiang et al
APBs are, by definition, a subset of PML bodies, and are present in only o5% of exponential dividing ALT cells, in contrast to the presence of PML bodies in almost every cell. Depletion of Sp100 did not affect the level of PML protein, and had no apparent effect on the formation of PML bodies and APBs, confirming our recent report that Sp100 is not required for APB formation (Jiang et al., 2005) . Our demonstration, however, that knockdown of PML abolishes PML bodies and inhibits assembly of APBs supports the notion that PML protein serves as a scaffold for the assembly of APBs.
In addition to being present in APBs, the MRN complex has been shown to be associated with telomeres (Zhu et al., 2000) . RAD50, MRE11 and NBS1 are present in TRF2 immunocomplexes (Zhu et al., 2000) via their interaction with RAP1 (O'Connor et al., 2004) . RAD50 and MRE11 are located at telomeres throughout interphase, and are joined by NBS1 in S-phase (Zhu et al., 2000) . It has been suggested that MRE11 and RAD50 may be required to stabilize telomere (t)-loop formation (which is essentially an unresolved homologous recombination event) throughout most of the cell cycle, and that the transient recruitment of NBS1 in Sphase may be required for access of the DNA replication machinery (Zhu et al., 2000) . The observation that sequestration of MRE11/RAD50/NBS1 by Sp100 led to suppression of both ALT activity and APB formation suggested a vital role of MRN complexes in the recombinational activity required for ALT and generation of APBs (Jiang et al., 2005) . Consistent with this, our data show that knockdown of any member of the MRN complex disrupts APB formation, indicating that the functional integrity of MRN complexes is important for the assembly of APBs.
53BP1, which was originally identified as a binding protein of p53 (Iwabuchi et al., 1994) , is a putative DNA damage sensor that accumulates at sites of doublestrand breaks to form ionizing radiation-induced nuclear foci (Schultz et al., 2000; Anderson et al., 2001; Rappold et al., 2001 ). 53BP1 has recently been shown to be associated with uncapped telomeres upon disruption of TRF2 function, forming a telomere dysfunction-induced focus (TIF) with other DNA damage response factors such as gamma-H2AX, RAD17, ATM and MRE11 (Takai et al., 2003; Xu and Blackburn, 2004) . We showed here for the first time that 53BP1 partially co-localizes with APBs. However, knockdown of 53BP1 had no obvious effects on APB formation. A possible explanation is that TIFs and APBs might co-localize under some circumstances.
TRF1, TRF2, TIN2 and RAP1 are four telomereassociated proteins that are members of the so-called 'shelterin complex', which safeguards the integrity of human telomeres (de Lange, 2005) . TRF1 and TRF2 directly bind double-stranded telomeric DNA, and although related, they have very different functions. TRF1 functions as a negative regulator of telomere length (van Steensel and de Lange, 1997), whereas TRF2 is important for maintaining telomere capping (van Steensel et al., 1998; Karlseder et al., 1999). The functions of TRF1 and TRF2 are interconnected and integrated by TIN2 (Houghtaling et al., 2004; Kim et al., 2004; . Also, TRF2 binds RAP1 (Li et al., 2000) , which recruits MRN complexes (Zhu et al., 2000; O'Connor et al., 2004) . Functional impairment of any of these proteins by RNA interference or expression of a dominant negative protein has shown that all four proteins negatively regulate telomere length in telomerasepositive cells (van Steensel and de Lange, 1997; van Steensel et al., 1998; Li and de Lange, 2003; O'Connor et al., 2004; Ye and de Lange, 2004) . Although the functions of these proteins in ALT, including APB assembly, are largely unknown, all four proteins are present in APBs (Yeager et al., 1999; Wu et al., 2003; this study) . In the present study, we showed that knockdown of any of the TRF1, TRF2, TIN2 and RAP1 represses APB formation, suggesting that all four proteins are required -directly or indirectly -for the assembly of APBs, and hence for ALT-mediated telomere lengthening. This is in contrast with the roles of these proteins as negative regulators of telomere length in telomerase-positive cells. The contrasting roles may presumably be explained by the differences in the mechanisms (recombination-mediated DNA replication versus telomerase-mediated reverse transcription). It seems likely that maintaining the integrity of telomeric DNA is important for the formation of APBs as well as for telomere maintenance in ALT-positive cells.
Our results demonstrated that TRF1, TRF2, TIN2 and RAP1 foci are co-regulated: knockdown of any of these proteins except RAP1 resulted in decreased foci of the other proteins. This is in agreement with a previous report that in telomerase-positive cells removal of TRF1 or TIN2 from telomeres causes a concomitant loss of TRF2 and RAP1 . Thus, TRF1, TRF2 or TIN2 could be acting indirectly in ALT-positive cells via their effects on one or more of the other shelterin proteins. The effect of RAP1 could also be indirect in that it acts as a bridge between telomeres and MRN complexes.
We monitored cell numbers in all experiments, and observed no decrease in viability following the siRNA treatments (compared with control siRNA), even when proteins essential for telomere maintenance such as TRF2 were knocked down to very low levels. There are two possible explanations for this lack of toxicity. First, IIICF/c cells, like most ALT cell lines, do not have a functional p53 pathway and appear to be highly tolerant of chromosome ends that have no detectable telomere sequence. Second, in this assay the proteins are depleted under conditions (methionine restriction and growth arrest) that may limit adverse responses to the knockdown of target proteins.
In summary, the reversible induction of APBs by methionine restriction was exploited by combining it with RNA interference to screen 10 candidate genes for their involvement in APB formation. On the basis of these findings and our previous work as well as the results of others, we propose a hypothetical model for how APBs might be assembled (Figure 7 ). Lowmolecular-weight telomeric DNA may be generated by resolution of the Holliday junction-like structure involved in the formation of t-loops (Wang et al., 2004) , a process sometimes referred to as 'looping out'. This telomeric DNA remains bound to members of the shelterin complex, which need to interact with the MRN complex to translocate to PML bodies.
In addition to providing insights into APB formation, this assay provides an alternative method for studying genes potentially involved in the ALT mechanism, because there is an excellent correlation between the presence of APBs and ALT activity (Jiang et al., 2005) . This is particularly important because some ALT genes might be vital to cells, and thus not suitable for studies involving gene targeting or long-term knockdown. However, the candidate ALT genes identified in this way still need to be verified by other means, since the possibility cannot be excluded that the genes required for APBs are dispensable for ALT, and vice versa.
Materials and methods
Cell culture and methionine restriction
The spontaneously immortalized Li-Fraumeni syndrome fibroblast line IIICF/c (Rogan et al., 1995) , SV40-immortalized human fibroblasts GM847DM (from Dr O PereiraSmith) and GM00639 (Coriell), hTERT-immortalized human fibroblasts JFCF-6/hTERT/3 (Z Zhong et al., unpublished) and IMR90 primary fibroblasts (American-type culture collection (ATCC)) were cultured in Dulbecco's modified Eagle's medium (DMEM) containing 10% fetal bovine serum (FBS) and 50 mg/ml gentamicin in a 5% CO 2 -humidified atmosphere at 371C.
For methionine restriction, cells were seeded in normal medium and grown to about 50% confluency. Cells were washed once with methionine-free medium before changing to this medium. After 4 days, cells were either fixed for immunostaining, or harvested for isolation of protein.
Methionine-or cystine-deficient medium was reconstituted from methionine-and cystine-deficient DMEM (GIBCO, Rockville, MD, USA) by adding L-cystine (48 mg/l, GIBCO) or L-methionine (30 mg/l, Sigma, St Louis, MO, USA), respectively. For the analysis of homocysteine dependency, L-homocysteine (30 mg/l, Sigma) was added into methioninedeficient medium.
Antibodies
The following antibodies were used in this study: mouse anti-NBS1, anti-MRE11, anti-RAD50, anti-53BP1 and anti-BrdU (BD Biosciences, San Jose, CA, USA); mouse anti-RAD50 (GeneTex, San Antonio, TX, USA); rabbit anti-NBS1 (Ab-1) and anti-MRE11 (Ab-1) (Oncogene Research Products, Boston, MA, USA); goat anti-NBS1 (C-19), goat anti-PML (N-19) and mouse anti-PML (Santa Cruz Biotechnology, Santa Cruz, CA, USA); rabbit anti-Sp100 and anti-PML (Chemicon, Temecula, CA, USA); mouse anti-Ki-67 (DAKO, Glostrup, Denmark); mouse anti-MCM7 (Sigma); mouse anti-TRF2 (Upstate Biotechnology, Waltham, MA, USA); rabbit anti-RAP1 (Novus Biologicals) and mouse anti-TIN2 (Imgenex, San Diego, CA, USA). Polyclonal anti-TRF1 rabbit serum was raised against a TRF1 peptide, residues 13-35.
Cell-cycle analysis and BrdU labeling Cells were grown on six-well plates to about 50% confluency and then subjected to methionine restriction. Four days later, methionine was added to the medium for various time periods (0, 1, 2 and 3 days), after which cells were collected and stained for cell-cycle analysis. Single-cell suspensions of 1-2 Â 10 5 cells were mixed with 0.1 ml of 5% Triton X-100 (Merck, San Diego, CA, USA), 0.5 mg of ribonuclease A (Sigma), 25 mg of propidium iodide and phosphate-buffered saline (PBS) to a final volume of 0.3 ml, as described (Smyth et al., 1993) . Cells were incubated for 1 h on ice before being analysed by flow cytometry.
For BrdU labeling of methionine-starved cells, cells were grown in four-well chamber slides to about 50% confluency and then methionine starved for 4 days. BrdU (100 mM, Roche, Basel, Switzerland) was added to the culture medium for 3 h before fixation. The BrdU staining was performed according to the manufacturer's instructions (Roche). For methionine stimulation, methionine was added to the methionine-starved cells for 24 h and 10 mM BrdU was added to the culture medium 2 h before the slides were fixed. These samples were double stained for BrdU and TRF1 (see section on Immunostaining).
RNA interference
The following short-interfering RNAs (siRNAs) were designed and synthesized by Qiagen (Hilden, Germany): for MRE11, 5 0 -CTGCCTCGAGTTATTAAGAAA-3 0 (MRE11-2); for RAD50, 5 0 -TAAGATTGAATTGAATCGTAA-3 0 (RAD50-1) and 5 0 -CTGCGACTTGCTCCAGATAAA-3 0 (RAD50-2); for NBS1, 5 0 -AAGAAGCAGCCTCCACAAATT-3 0 (NBS1-2); for Sp100, 5 0 -CAGGAAATTATGATAAACTCA-3 0 (Sp100-1) and 5 0 -AACCATGGAATCCAAATTAAT-3 0 (Sp100-2); for TIN2, 5 0 -ACGCCTTTGTATGGGCCTAAA-3 0 (TIN2-4); and for RAP1, To determine the extent of knockdown, IIICF/c cells were transfected with 10 nM siRNA using HiPerFect transfection reagent according to the manufacturer's instruction (Qiagen). For Western analysis, cells were seeded into six-well plates 1 day before siRNA transfection. After transfection for 48 h, cells were harvested for protein isolation.
APB screening by RNA interference and methionine starvation Cells were seeded into four-well chamber slides (Nunc, Naperville, IL, USA) 1 day before transfection of siRNAs. siRNA 10 nM was transfected into cells using HiPerFect (Qiagen), and 48 h later cells were transfected again and methionine restricted. Four days later, cells were fixed and immunostained for the target protein and APBs (co-localization of TRF1, TRF2 or telomeric DNA with PML bodies). Finally, APB positivity was scored for the cells in which the target protein was depleted.
Immunostaining, telomere FISH and fluorescence microscopy Cells grown in four-well chamber slides were fixed for 15 min in 2% paraformaldehyde at room temperature, and then permeated with methanol/acetone (1:1) at À201C for 15 min. Cells were incubated overnight with primary antibodies at 41C, and then were incubated with fluorescently conjugated secondary antibodies at room temperature for 40 min. In some cases, DAPI (Sigma) was included in the secondary incubation to visualize DNA. Finally, the preparations were mounted in anti-fading medium containing 1,4-diazabicyclo [2.2.2] octane (DABCO, Sigma). The secondary antibodies used were as follows: AMCA-, FITC-or Texas Red-conjugated donkey anti-mouse, AMCA-, FITC-or Texas Red-conjugated donkey anti-rabbit, AMCA-or Texas Red-conjugated donkey antigoat, FITC-or Texas Red-conjugated goat anti-rabbit and FITC-or Texas Red-conjugated goat anti-mouse (Jackson ImmunoResearch, West Grove, PA, USA).
For the TIN2 stainings, two layers of secondary antibodies (Texas Red-conjugated goat anti-mouse and donkey anti-goat) were required to enhance the signals to an adequate level. For double staining of BrdU and TRF1, fixed cells were incubated with 2 mg/ml Dnase I (Sigma) for 30 min at 371C before incubation of primary antibodies. Double or triple staining of telomeric DNA and APBassociated proteins was performed as previously described . Briefly, slides were first immunostained with primary and secondary antibodies, and then cross-linked with 4% formaldehyde and dehydrated. Telomere FISH was performed by using a Cy3-or FITC-conjugated telomerespecific peptide nucleic acid (PNA) probe (Applied Biosystems, Framingham, MA, USA).
The samples were examined on a Leica DMLB fluorescence microscope. Images were recorded using a Spot-cooled CCD camera (SPOT2; Diagnostic Instruments, Sterling Heights, MI, USA) and analysed with PhotoShop 6.0 (Adobe, San Jose, CA, USA).
Immunoblotting
For immunoblotting analyses, cell lysates were prepared, electrophoretically separated on SDS-PAGE gels and electrotransferred to a nylon membrane as described previously (Toouli et al., 2002) . Immunoblotting procedures were as recommended by the antibody suppliers. Horseradish peroxidase (HRP)-conjugated goat anti-mouse or swine anti-rabbit IgG (DAKO) were used as secondary antibodies.
